Zobrazeno 1 - 10
of 114
pro vyhledávání: '"insulin intensification"'
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 8, Iss 10, Pp 3096-3107 (2019)
Type 2 diabetes is characterised by a progressive decline in insulin secretion, and sooner or later patients require insulin therapy. However, physicians are reluctant to initiate insulin therapy because of perceived inadequacy in managing insulin th
Externí odkaz:
https://doaj.org/article/5cce74fb39924e0199c5ea6c8b438c8f
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 9, Pp 749-762 (2017)
Marek Psota,1 Maria Bucek Psenkova,1 Natalia Racekova,2 Antonio Ramirez de Arellano,3 Tom Vandebrouck,4 Barnaby Hunt5 1Pharm-In, Ltd., 2Novo Nordisk Ltd., Bratislava, Slovakia; 3Novo Nordisk Ltd., Madrid, Spain; 4Novo Nordisk nv, Brussels, Belgium; 5
Externí odkaz:
https://doaj.org/article/b1f57af1f03d45e0889312b719ea1669
Publikováno v:
Сахарный диабет, Vol 20, Iss 5, Pp 363-373 (2017)
Maintaining glycemic control through intensive clinical management of patients with type 2 diabetes mellitus (T2DM) is well recognized to reduce the risk of diabetes-associated complications. Patients in Russia have high rates of microvascular and ma
Externí odkaz:
https://doaj.org/article/7064630c00a648cdb4fccd13437a7832
Autor:
Riccardo Candido, Olga Disoteo, Paolo Di Bartolo, Gian Paolo Fadini, Luigi Laviola, Agostino Consoli
Publikováno v:
Diabetes Therapy
Introduction The aim of this study was to elaborate a consensus on treatment intensification strategies in patients with type 2 diabetes failing basal insulin supported oral therapy (BOT). The panel focused on glucagon-like peptide-1 receptor agonist
Autor:
Miguel Brito, Robert Jan Ligthelm, Massimo Boemi, Ajay Kumar, Itamar Raz, Teresa Koblik, Yan Gao, Jens Sandahl Christiansen
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 15, Iss 3, Pp 152-160 (2011)
In 2009, consensus guidelines were published on intensification of insulin therapy using the premix analog biphasic insulin aspart (BIAsp) 30 in the treatment of type 2 diabetes, based on the recommendations of an international, independent expert pa
Externí odkaz:
https://doaj.org/article/fc9273f575454747b7e57b10914336e0
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 8, Iss 10, Pp 3096-3107 (2019)
Journal of Family Medicine and Primary Care
Journal of Family Medicine and Primary Care
Type 2 diabetes is characterised by a progressive decline in insulin secretion, and sooner or later patients require insulin therapy. However, physicians are reluctant to initiate insulin therapy because of perceived inadequacy in managing insulin th
Autor:
Olufemi Fasanmade, Sanjay Kalra, Jean Claude Mbanya, Rima Tan, Roberta Lamptey, Kaushik Ramaiya, Mustafa Araz, Chaicharn Deerochanawong, Ajay Kumar, Dina Shrestha, Syed Abbas Raza, Hinde Iraqi, Magdy H. Megallaa, AG Unnikrishnan, Eugene Sobngwi, Joel Rodriguez-Saldana, Ali Latheef, Tint Swe Latt, Zhanay Akanov, Nguyen Quang Bay, Leszek Czupryniak, Sandeep Chaudhary, Norlela Sukor, Noel Somasundaram, Khalid Shaikh, Gary Kilov, Silver Bahendeka, Ko Seung Hyun, Maxim Lushchyk, Ralph Audehm, Mohammed Wali Naseri, Aissa Boudiba, Mohamed Abid, Hoosen Randeree, Zafar Ahmed Latif, Naby Balde
Publikováno v:
Diabetes Therapy
Premixed insulins are an important tool for glycemic control in persons with diabetes. Equally important in diabetes care is the selection of the most appropriate insulin regimen for a particular individual at a specific time. Currently, the choice o
Autor:
Cariou, B.
Publikováno v:
In Diabetes and Metabolism December 2015 41(6) Supplement 1
Autor:
Darmon, P., Raccah, D.
Publikováno v:
In Diabetes and Metabolism December 2015 41(6) Supplement 1
Publikováno v:
In Diabetes and Metabolism December 2015 41(6) Supplement 1